3D Cell Culture Market is Expected to Exhibit a CAGR of 23.4% by forecast 2021-2028 | Thermo Fisher Scientific Inc., Lonza, Merck KGaA, Becton

Growing cases infectious diseases and cancer is expected to boost the global 3D cell culture market growth over the forecast period. Moreover, increasing demand for 3D cell culture for treatment of numerous diseases is expected to accelerate the market growth in the near future. According to the World Health Organization (WHO), September 2018 data finding, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths globally in 2018. Furthermore, according to the same source, globally, about one in six deaths occur due to cancer. According to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths were reported in the U.S.

Request Sample Report + Related Graphs & Charts @:
https://www.coherentmarketinsights.com/insight/request-sample/534

Key Players in This Report Include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.

3D cell culture techniques are emerging as versatile and biologically relevant research models to help support the current fight against COVID-19. Stem cells are emerging as a favored model to predict what type of cell can be permissive to certain types of viruses, giving insight to scientists and clinicians alike and offering advantages over the limited resources of biobanks for human tissue, in vitro Petri dish cultures or animal models. Several companies are supporting the research and development activities using 3D cell cultures for development of new screening and therapy platforms.

For instance, in January 2021, Corning Incorporated highlighted its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery as new solutions to support evolving industry needs such as COVID-19 response, disease models, and drug discovery at this year's 2021 virtual Society for Laboratory Automation and Screening (SLAS) conference.

Moreover, in November 2020, Biogelx is aiming to provide UK-Spanish research groups working on COVID-19 vaccines with advanced 3D cell culture to mitigate risk arising during drug development and testing processes. Biogelx is committed to supporting the scientific community working on COVID-19 vaccines research. In October 2020, a study published in Cell Press Journal, reported that a team of scientists from the U.K. and South Korea turned to organoids—'miniorgans' grown in three dimensions to mimic the behavior of tissue and organs.

The scientists were able to grow self-organizing alveolar-like 3D structures that mimic the behavior of key lung tissue for understanding how the COVID-19 affects the lungs. The mini-lungs grown from tissue donated to Cambridge hospitals have provided a team of scientists with important insights into how COVID-19 damages the lungs. In new work, the researchers explained the mechanisms underlying SARS-CoV-2 infection and the early innate immune response in the lungs.

Key companies are focused on adopting inorganic growth strategies, in order to enhance the market presence. For instance, in June 2020, Lonza Group entered into a partnership with the Sweden-based company, CELLINKto offer a comprehensive 3-dimensional (3D) bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.

Request for customization in Report @ https://www.coherentmarketinsights.com/insight/request-customization/534

Key Takeaways

• The global 3D cell culture market is expected exhibiting a CAGR of 22.4% over the forecast period, owing to rising product launches. For instance, in January 2019, Visikol, a 3D cell culture characterization and analysis company, announced the launched OpenLiver 3D cell culture models to accelerate drug discovery. Visikol expanded its service offering through the introduction of its own liver 3D cell culture models.

• On the basis of application, drug discovery segment is expected to register the highest CAGR, owing to ongoing R&D activities. For instance, according to data published by Syracuse University in March 2018, Professor Zhen Ma and his research team developed a process that combines biomaterials-based cell patterning and stem cell technology to make a 3D tissue model that could mimic early stage human heart development. This heart could be used for testing the effects of drugs on the human heart, prior to the clinical trials or during the clinical trials.

• On the basis of end-user, biopharmaceutical segment is expected to hold dominant position, owing to growing focus on product launches. For instance, in March 2019, Lonza launched Custom Cell Biology Services for pharmaceutical companies and contract manufacturing organizations. Lonza provides services such as cell-line expansion and banking, media production, cell isolation, cell characterization, transfection services, and 3-dimensional cell-culture services.

• On the basis of region, Asia Pacific is expected to register the highest CAGR, owing to increasing healthcare expenditure. For instance, according to the Ministry of Health, Labour and Welfare, Japan spent an estimated US$ 3,054 million per capita on healthcare in 2018, which is US$ 35.50 million more than the previous year.

Get Discount On The Purchase Of This Report @: https://www.coherentmarketinsights.com/promo/buynow/534

3D Cell Culture Market research provides answers to the following key questions:

• What is the expected growth rate of the 3D Cell Culture Market?

• What will be the 3D Cell Culture Market size for the forecast period, 2021–2028?

• What are the main driving forces responsible for changing the 3D Cell Culture Market trajectory?

• Who are the big suppliers that dominate the 3D Cell Culture Market across different regions? Which are their wins to stay ahead in the competition?

• What are the 3D Cell Culture Market trends business owners can rely upon in the coming years?

• What are the threats and challenges expected to restrict the progress of the 3D Cell Culture Market across different countries?

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights :

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.